|
2 Companies |
|
1 Product |
|
1 Product |
|
3 Mechanisms of Action |
|
0 Trials |
|
9 News |
|
- Enrollment change, Trial withdrawal: A Clinical Trial to Study the Efficacy and Safety of Stempeucel (clinicaltrials.gov) - Apr 7, 2017
P2, N=0, Withdrawn, Sponsor: Stempeutics Research Pvt Ltd
N=164 --> 0 | Not yet recruiting --> Withdrawn
- ||||| New P2 trial: A Clinical Trial to Study the Efficacy and Safety of Stempeucel (clinicaltrials.gov) - Feb 16, 2017
P2, N=164, Not yet recruiting, Sponsor: Stempeutics Research Pvt Ltd
- Trial completion, Enrollment change: ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease (clinicaltrials.gov) - Nov 10, 2016
P=N/A, N=224, Completed, Sponsor: University Hospital, Lille
N=164 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=400 --> 224
- |||| Trial completion, Enrollment change, Trial primary completion date: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease (clinicaltrials.gov) - Sep 15, 2016
P2, N=90, Completed, Sponsor: Stempeutics Research Pvt Ltd
Recruiting --> Completed | N=400 --> 224 Recruiting --> Completed | N=126 --> 90 | Trial primary completion date: Sep 2013 --> Feb 2014
- Trial primary completion date: ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=400, Recruiting, Sponsor: University Hospital, Lille
Recruiting --> Completed | N=126 --> 90 | Trial primary completion date: Sep 2013 --> Feb 2014 Trial primary completion date: Sep 2013 --> Sep 2016
- New P1/2 trial: Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia (clinicaltrials.gov) - May 8, 2012
P1/2, N=8, Completed, Sponsor: IRCCS Policlinico S. Matteo
- |||| Enrollment open: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease (clinicaltrials.gov) - Jan 11, 2012
P2, N=126, Recruiting, Sponsor: Stempeutics Research Pvt Ltd
Trial primary completion date: Sep 2013 --> Sep 2016 Not yet recruiting --> Recruiting
- ||||| New P2 trial: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease (clinicaltrials.gov) - Nov 26, 2011
P2, N=126, Recruiting, Sponsor: Stempeutics Research Pvt Ltd